Author: Miasuma
-
Why Is CCC Stock Up? CCC Intelligent Solutions Sale Report, Takeover Premium and M&A Risks
Why Is CCC Stock Up? CCC Intelligent Solutions Sale Report, Takeover Premium and M&A…
READ MORE: Why Is CCC Stock Up? CCC Intelligent Solutions Sale Report, Takeover Premium and M&A RisksBY
-
Why Is RXT Stock Up? Rackspace’s 30MW AI Pivot vs. Debt and $250M Dilution Risk
Why Is RXT Stock Up? Rackspace’s 30MW AI Pivot vs. Debt and $250M Dilution…
READ MORE: Why Is RXT Stock Up? Rackspace’s 30MW AI Pivot vs. Debt and $250M Dilution RiskBY
-
EQPT Stock: Is EquipmentShare’s $500M Buyback Enough to Offset Its Debt Risk?
EQPT Stock: Is EquipmentShare’s $500M Buyback Enough to Offset Its Debt Risk? EquipmentShare.com Inc.…
READ MORE: EQPT Stock: Is EquipmentShare’s $500M Buyback Enough to Offset Its Debt Risk?BY
-
WDFC Stock Analysis: WD-40 Surges on 24% Revenue Growth, Raised Guidance and $100M Buyback
WDFC Stock Analysis: WD-40 Surges on 24% Revenue Growth, Raised Guidance and $100M Buyback…
READ MORE: WDFC Stock Analysis: WD-40 Surges on 24% Revenue Growth, Raised Guidance and $100M BuybackBY
-
LASR Stock Analysis: nLIGHT Surges as HADES Directed Energy Lasers and Defense Demand Drive Revaluation
LASR Stock Analysis: nLIGHT Surges as HADES Directed Energy Lasers and Defense Demand Drive…
READ MORE: LASR Stock Analysis: nLIGHT Surges as HADES Directed Energy Lasers and Defense Demand Drive RevaluationBY
-
BABA Stock Analysis: Alibaba Surges as AI Cloud Growth, Qwen and China Tech Rally Drive Revaluation
BABA Stock Analysis: Alibaba Surges as AI Cloud Growth, Qwen and China Tech Rally…
READ MORE: BABA Stock Analysis: Alibaba Surges as AI Cloud Growth, Qwen and China Tech Rally Drive RevaluationBY
-
PENG Stock: Penguin Solutions Surges After Q3 Earnings, Integrated Memory Growth and AI Factory Demand
PENG Stock: Penguin Solutions Surges After Q3 Earnings, Integrated Memory Growth and AI Factory…
READ MORE: PENG Stock: Penguin Solutions Surges After Q3 Earnings, Integrated Memory Growth and AI Factory DemandBY
-
AGIO Stock Analysis: Mitapivat FDA Priority Review, November 2026 PDUFA Date and the Sickle Cell Disease Opportunity
AGIO Stock Analysis: Mitapivat FDA Priority Review, November 2026 PDUFA Date and the Sickle…
READ MORE: AGIO Stock Analysis: Mitapivat FDA Priority Review, November 2026 PDUFA Date and the Sickle Cell Disease OpportunityBY
-
DOCN Stock Analysis: DigitalOcean’s AI-Native Cloud, 221% AI ARR Growth and the Intraday Reversal Risk
DOCN Stock Analysis: DigitalOcean’s AI-Native Cloud, 221% AI ARR Growth and the Intraday Reversal…
READ MORE: DOCN Stock Analysis: DigitalOcean’s AI-Native Cloud, 221% AI ARR Growth and the Intraday Reversal RiskBY
-
SHAZ Stock Analysis: SharonAI’s NVIDIA AI Factory Deal, 40,000 GB300 GPUs and the Risks Investors Should Know
SHAZ Stock Analysis: SharonAI’s NVIDIA AI Factory Deal, 40,000 GB300 GPUs and the Risks…
READ MORE: SHAZ Stock Analysis: SharonAI’s NVIDIA AI Factory Deal, 40,000 GB300 GPUs and the Risks Investors Should KnowBY